Alex Sapir - Jul 1, 2023 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
President & Chief Executive Officer Exhibit Index: 24.1 Power of Attorney, Director
Signature
/s/ Gregory Tourangeau as attorney-in-fact for Alex Sapir
Stock symbol
FULC
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
3
Date filed
7/3/2023, 04:16 PM
Previous filing
May 19, 2023
Next filing
Mar 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FULC Stock Option (right to buy) Jul 1, 2023 Common Stock 2.43M $3.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 12, 2023 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of May 12, 2023. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.

Remarks:

President & Chief Executive Officer Exhibit Index: 24.1 Power of Attorney